Mice deficient in cytosolic phospholipase A2 are less susceptible to cerebral ischemia/reperfusion injury
- PMID: 14753428
- DOI: 10.1007/978-3-7091-0651-8_36
Mice deficient in cytosolic phospholipase A2 are less susceptible to cerebral ischemia/reperfusion injury
Abstract
To determine the role of cytosolic phospholipase A2 (cPLA2) in infarct development, wild-type and cPLA2 knock-out mice were subjected to focal cerebral ischemia for 75 min by occluding the middle cerebral artery using nylon filament and subsequent reperfusion by withdrawing the filament. The neurological deficit severity was evaluated by a modified 4-point scale. After the reperfusion period (72 h), mice were killed, and the brains were cut into four 2 mm coronal sections using a rodent brain matrix. Sections were stained with 2% 2,3,5-triphenyltetrazolium chloride (TTC). The infarct volume was 87.19 +/- 27.54 mm3 (mean +/- SD, n = 11) in the wild-type mice and 48.20 +/- 31.32 mm3 (n = 10; P < 0.01 vs. wild-type) in the knock-out mice. Less severe functional neurological deficits were observed in knock-out mice at 72 h after ischemia when compared with wild-type. Thus, disruption of cPLA2 resulted in significant reduction of infarct area and neurological deficit severity in the MCA occlusion model. These data indicate a critical role for cPLA2 in the pathogenesis of cerebral ischemia/ reperfusion injury.
Similar articles
-
Reduced fertility and postischaemic brain injury in mice deficient in cytosolic phospholipase A2.Nature. 1997 Dec 11;390(6660):622-5. doi: 10.1038/37635. Nature. 1997. PMID: 9403693
-
Phospholipases A2 in ischemic and toxic brain injury.Neurochem Res. 2000 May;25(5):745-53. doi: 10.1023/a:1007583708713. Neurochem Res. 2000. PMID: 10905638 Review.
-
Chronic intracerebroventricular delivery of the secretory phospholipase A2 inhibitor, 12-epi-scalaradial, does not improve outcome after focal cerebral ischemia-reperfusion in rats.Exp Brain Res. 2007 Jan;176(2):248-59. doi: 10.1007/s00221-006-0611-7. Exp Brain Res. 2007. PMID: 16874515
-
Mice deficient in Mac-1 (CD11b/CD18) are less susceptible to cerebral ischemia/reperfusion injury.Stroke. 1999 Jan;30(1):134-9. doi: 10.1161/01.str.30.1.134. Stroke. 1999. PMID: 9880401
-
Endothelin, cerebral ischaemia and infarction.Clin Exp Hypertens. 1995 Jan-Feb;17(1-2):399-407. doi: 10.3109/10641969509087080. Clin Exp Hypertens. 1995. PMID: 7735285 Review.
Cited by
-
Lysosomal release of cathepsins causes ischemic damage in the rat hippocampal slice and depends on NMDA-mediated calcium influx, arachidonic acid metabolism, and free radical production.J Neurochem. 2008 Jul;106(1):56-69. doi: 10.1111/j.1471-4159.2008.05349.x. Epub 2008 Jul 1. J Neurochem. 2008. PMID: 18363826 Free PMC article.
-
The Alpha Keto Amide Moiety as a Privileged Motif in Medicinal Chemistry: Current Insights and Emerging Opportunities.J Med Chem. 2021 Apr 8;64(7):3508-3545. doi: 10.1021/acs.jmedchem.0c01808. Epub 2021 Mar 25. J Med Chem. 2021. PMID: 33764065 Free PMC article. Review.
-
The autotaxin-lysophosphatidic acid-lysophosphatidic acid receptor cascade: proposal of a novel potential therapeutic target for treating glioblastoma multiforme.Lipids Health Dis. 2015 Jun 18;14:56. doi: 10.1186/s12944-015-0059-5. Lipids Health Dis. 2015. PMID: 26084470 Free PMC article. Review.
-
Cytosolic phospholipase A2 protein as a novel therapeutic target for spinal cord injury.Ann Neurol. 2014 May;75(5):644-58. doi: 10.1002/ana.24134. Epub 2014 Apr 2. Ann Neurol. 2014. PMID: 24623140 Free PMC article.
-
Regulation of Wnt/beta-catenin pathway by cPLA2alpha and PPARdelta.J Cell Biochem. 2008 Oct 1;105(2):534-45. doi: 10.1002/jcb.21852. J Cell Biochem. 2008. Retraction in: J Cell Biochem. 2015 Apr;116(4):686. doi: 10.1002/jcb.25020. PMID: 18636547 Free PMC article. Retracted.